Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a clinical-stage biopharmaceutical company advancing ...
Carlsbad, CA, May 27, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (PALI) (“Palisade”, “Palisade Bio”, or the “Company”), a clinical-stage biopharmaceutical company focused on developing and advancing ...
Virtual fireside chat scheduled for Thursday, February 12, 2026, from 1:30 PM to 1:55 PM ETAccess the webcast hereCarlsbad, CA, Feb. 09, 2026 ...
Patients with Crohn's disease who undergo terminal ileum resection have a significantly higher risk of developing colorectal cancer (CRC) and colorectal polyps than those who do not undergo resection.
Virtual presentation scheduled for Thursday, February 26th at 12:40 PM ET Access the webcast hereCarlsbad, CA, Feb. 05, 2026 (GLOBE NEWSWIRE) ...
Findings from the post-hoc analysis of LIBERTY-CD study indicates efficacy of ZYMFENTRA® (subcutaneous infliximab) regardless of disease location, consistent across ileum-dominant and colon-dominant ...
The gut microbiome is an important ecosystem of microbes that lives in each one of us, and its strength affects our overall health. However, the small intestine is an underappreciated part of the gut ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results